These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 27729349
21. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M, Twisk FN, Ringel K. Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [Abstract] [Full Text] [Related]
22. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, Leite JC, Poland F, Howe A, Drachler ML. BMC Med; 2011 Jul 28; 9():91. PubMed ID: 21794183 [Abstract] [Full Text] [Related]
23. Chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME) is different in children compared to in adults: a study of UK and Dutch clinical cohorts. Collin SM, Nuevo R, van de Putte EM, Nijhof SL, Crawley E. BMJ Open; 2015 Oct 28; 5(10):e008830. PubMed ID: 26510728 [Abstract] [Full Text] [Related]
24. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Kim DY, Lee JS, Park SY, Kim SJ, Son CG. J Transl Med; 2020 Jan 06; 18(1):7. PubMed ID: 31906979 [Abstract] [Full Text] [Related]
25. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID). Huth TK, Eaton-Fitch N, Staines D, Marshall-Gradisnik S. J Transl Med; 2020 May 13; 18(1):198. PubMed ID: 32404171 [Abstract] [Full Text] [Related]
26. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England. Strassheim VJ, Sunnquist M, Jason LA, Newton JL. BMJ Open; 2018 Sep 19; 8(9):e020775. PubMed ID: 30232103 [Abstract] [Full Text] [Related]
27. What is in a name? Comparing diagnostic criteria for chronic fatigue syndrome with or without fibromyalgia. Meeus M, Ickmans K, Struyf F, Kos D, Lambrecht L, Willekens B, Cras P, Nijs J. Clin Rheumatol; 2016 Jan 19; 35(1):191-203. PubMed ID: 25308475 [Abstract] [Full Text] [Related]
28. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. Maksoud R, Balinas C, Holden S, Cabanas H, Staines D, Marshall-Gradisnik S. J Transl Med; 2021 Feb 17; 19(1):81. PubMed ID: 33596913 [Abstract] [Full Text] [Related]
29. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S. BMC Neurol; 2019 Aug 24; 19(1):207. PubMed ID: 31445522 [Abstract] [Full Text] [Related]
30. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Corbitt M, Campagnolo N, Staines D, Marshall-Gradisnik S. Probiotics Antimicrob Proteins; 2018 Sep 24; 10(3):466-477. PubMed ID: 29464501 [Abstract] [Full Text] [Related]
31. A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Collatz A, Johnston SC, Staines DR, Marshall-Gradisnik SM. Clin Ther; 2016 Jun 24; 38(6):1263-1271.e9. PubMed ID: 27229907 [Abstract] [Full Text] [Related]
32. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. Chambers D, Bagnall AM, Hempel S, Forbes C. J R Soc Med; 2006 Oct 24; 99(10):506-20. PubMed ID: 17021301 [Abstract] [Full Text] [Related]
33. How common are depression and anxiety in adolescents with chronic fatigue syndrome (CFS) and how should we screen for these mental health co-morbidities? A clinical cohort study. Loades ME, Read R, Smith L, Higson-Sweeney NT, Laffan A, Stallard P, Kessler D, Crawley E. Eur Child Adolesc Psychiatry; 2021 Nov 24; 30(11):1733-1743. PubMed ID: 32964335 [Abstract] [Full Text] [Related]
34. Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review. Collard SS, Murphy J. J Child Health Care; 2020 Sep 24; 24(3):411-431. PubMed ID: 31379194 [Abstract] [Full Text] [Related]
35. Comparing specialist medical care with specialist medical care plus the Lightning Process for chronic fatigue syndrome or myalgic encephalomyelitis (CFS/ME): study protocol for a randomised controlled trial (SMILE Trial). Crawley E, Mills N, Hollingworth W, Deans Z, Sterne JA, Donovan JL, Beasant L, Montgomery A. Trials; 2013 Dec 26; 14():444. PubMed ID: 24370208 [Abstract] [Full Text] [Related]
36. A Novel Approach to Treating CFS and Co-morbid Health Anxiety: A Case Study. Daniels J, Loades ME. Clin Psychol Psychother; 2017 May 26; 24(3):727-736. PubMed ID: 27714891 [Abstract] [Full Text] [Related]
37. The Presentation of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Influenced by the Presence or Absence of Joint Hypermobility. Vogel SK, Primavera IR, Marden CL, Jasion SE, Cranston EM, Flaherty MAK, Violand RL, Rowe PC. J Pediatr; 2022 Jan 26; 240():186-191.e2. PubMed ID: 34537220 [Abstract] [Full Text] [Related]
38. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis. Du Preez S, Corbitt M, Cabanas H, Eaton N, Staines D, Marshall-Gradisnik S. Syst Rev; 2018 Dec 20; 7(1):241. PubMed ID: 30572962 [Abstract] [Full Text] [Related]
39. Systematic review of fatigue severity in ME/CFS patients: insights from randomized controlled trials. Park JW, Park BJ, Lee JS, Lee EJ, Ahn YC, Son CG. J Transl Med; 2024 Jun 03; 22(1):529. PubMed ID: 38831460 [Abstract] [Full Text] [Related]
40. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Impact on Quality of Life (QoL) of Persons with ME/CFS. Muirhead NL, Vyas J, Ephgrave R, Singh R, Finlay AY. Medicina (Kaunas); 2024 Jul 27; 60(8):. PubMed ID: 39202496 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]